Skip to main content
. 2013 Feb 28;8(5):787–796. doi: 10.2215/CJN.07570712

Figure 3.

Figure 3.

Alkylating agents plus corticosteroids significantly reduced all-cause mortality or risk of ESRD (A) and significantly increased complete or partial remission (B) at the end of follow-up compared with no treatment or ACEI or corticosteroid monotherapy. ACEI, angiotensin converting enzyme inhibitor; CI, confidence interval; IV, inverse variance method.